Literature DB >> 29681396

Racial variations in extracorporeal membrane oxygenation use following congenital heart surgery.

Titus Chan1, Cindy S Barrett2, Yuen Lie Tjoeng3, Jacob Wilkes4, Susan L Bratton5, Ravi R Thiagarajan6.   

Abstract

OBJECTIVES: Previous studies demonstrate racial and ethnic disparities among children undergoing congenital heart surgery. Extracorporeal membrane oxygenation (ECMO) is used to support critically ill children after congenital heart surgery and improve survival. Thus, racial or ethnic variations in postoperative ECMO use following congenital heart surgery may be associated with racial/ethnic disparities in hospital survival.
METHODS: All children in the Pediatric Health Information Systems dataset undergoing congenital heart surgery from 2004 to 2015 were examined. Multivariable, multinomial regression models examining hospital survival without ECMO use, survival after ECMO, death after ECMO, and death without ECMO support were constructed.
RESULTS: Of 130,860 congenital cardiac surgery patients, 95.4% survived to hospital discharge without requiring ECMO support, whereas 1.3% survived after ECMO support, 1.3% died after ECMO support, and 1.9% died without receiving ECMO support. After adjustment for other covariates, black patients (odds ratio, 1.22; 95% confidence interval [CI], 1.05-1.42) and patients of other race (odds ratio, 1.36; 95% CI, 1.17-1.58) were at increased odds of mortality compared with white patients. In multivariable multinomial models, black patients had increased risk of death without ECMO support (relative risk, 1.31; 95% CI, 1.11-1.56). Patients of other race (relative risk, 1.37; 95% CI, 1.10-1.69) and governmental insurance (relative risk, 1.24; 95% CI, 1.12-1.37) were also at increased risk of death without ECMO.
CONCLUSIONS: Black children and children of other race are at increased odds of mortality after congenital heart surgery. These disparities can be traced to variations in ECMO utilization across racial/ethnic groups.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital; disparities; extracorporeal membrane oxygenation; pediatric

Mesh:

Year:  2018        PMID: 29681396     DOI: 10.1016/j.jtcvs.2018.02.103

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Socioeconomic Impact on Outcomes During the First Year of Life of Patients with Single Ventricle Heart Disease: An Analysis of the National Pediatric Cardiology Quality Improvement Collaborative Registry.

Authors:  Sarah R de Loizaga; Kristin Schneider; Andrew F Beck; Huaiyu Zang; Nicholas Ollberding; James S Tweddell; Jeffrey B Anderson
Journal:  Pediatr Cardiol       Date:  2021-10-30       Impact factor: 1.655

2.  Disparities in surgical outcomes of neonates with congenital heart disease across regions, centers, and populations.

Authors:  Flora Nuñez Gallegos; Joyce L Woo; Brett R Anderson; Keila N Lopez
Journal:  Semin Perinatol       Date:  2022-03-13       Impact factor: 3.311

3.  Racial Disparities in Hospital Mortality Among Pediatric Cardiomyopathy and Myocarditis Patients.

Authors:  Jillian Olsen; Yuen Lie Tjoeng; Joshua Friedland-Little; Titus Chan
Journal:  Pediatr Cardiol       Date:  2020-10-06       Impact factor: 1.655

4.  Outcomes and factors associated with early mortality in pediatric and neonatal patients requiring extracorporeal membrane oxygenation for heart and lung failure.

Authors:  Farid Azizov; Julia Merkle; Javid Fatullayev; Kaveh Eghbalzadeh; Ilija Djordjevic; Carolyn Weber; Sergey Saenko; Axel Kroener; Mohamed Zeriouh; Anton Sabashnikov; Gerardus Bennink; Thorsten Wahlers
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  Social Determinants of Disparities in Mortality Outcomes in Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Richard Tran; Rebecca Forman; Elias Mossialos; Khurram Nasir; Aparna Kulkarni
Journal:  Front Cardiovasc Med       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.